Our results indicate that in view of the high prevalence of illicit AAS use, the self-administration of unapproved PCT using illegal and falsified medicines is dangerous and can be considered a potential threat to consumer health
Adding a second injection-only compound raises injection-site irritation risk and can compound fatigue during the early adaptation weeks
Layne Norton , Jeff Volek , Eric Ravussin , James Hill , Holly Nicastro, Ph.D., MPH , Tapan Mehta , Danny Lennon , Jordan Feigenbaum , Eric Trexler , Eric Holmes , Andrew Koutnik, Ph.D
Calculate Concentration 5 mg BPC-157 + 1 ml water = 5 mg/ml
Important note: it remains investigational and lacks FDA approval for human use
Those who experienced severe GI side effects on tirzepatide or semaglutide that required treatment discontinuation should proceed with extreme caution, as the combination will likely produce similar or potentially more pronounced effects